Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Sepalika a Healthcare...

    Sepalika a Healthcare content startup raises $750,000 from Accel

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2017-04-29T15:13:09+05:30  |  Updated On 17 Aug 2021 11:38 AM IST
    Sepalika, a healthcare content platform has raised $750,000 (Rs 4.8 crore) in seed funding led by venture capital firm Accel Partners. It offers research-based information on diet, lifestyle changes and supplements and helps in prevention and reversing chronic health conditions. The company was founded in 2016 by Sharda Agarwal and Mahesh Jayaraman. Agarwal previously worked with Coca-Cola, MarketGate.It mainly focuses on 11 chronic health conditions such as type-2 diabetes, cardiac diseases, hypertension, arthritis and mental health and depression.

    Barath Shankar Subramanian, principal in Accel, said, Sepalika's research-backed content platform aims to bring down the dependence on drugs and partner patients, caregivers, or experts in functional medicine to reverse chronic illnesses.

    The firm, owned and operated by Moonjur Healthcare Pvt Ltd., will use the capital to further enhance its platform and strengthen its core proposition, the statement added.

    The funds will be deployed towards building the platform and strengthening its core proposition. Sepalika aims to use the fresh capital infused for further building on its research-based content and strengthening its core proposition in the key market of the USA, Sharda Agarwal and Mahesh Jayaraman, Co-Founders, said on Friday.

    With this present fund flow he company is planning an advertising model for the content side of its business besides working on making its content available in local Indian languages.
    Accel PartnersBarath Shankar Subramanianfundinghealth venturesMahesh JayaramansepalikaSharda Agarwalvc fundVenture capital
    Source : ET health world

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok